ZIOPHARM Oncology Cash Flow

Health Care & Life Sciences » Biotechnology | ZIOPHARM Oncology Inc.

ZIOPHARM Oncology Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.

2013

2014

2015

2016

2017

2018

Net Income before Extraordinaries

57,107.00

31,781.00

120,088.00

165,297.00

54,323.00

53,117

Depreciation, Depletion & Amortization

738.00

462.00

357.00

290.00

369.00

575

Other Funds

2,907.00

6,980.00

75,282.00

127,599.00

9,749.00

7,376

Funds from Operations

53,462.00

38,299.00

44,449.00

37,408.00

44,205.00

45,166

Changes in Working Capital

6,047.00

1,649.00

44,439.00

20,917.00

10,464.00

4,291

Net Operating Cash Flow

59,509.00

36,650.00

10.00

58,325.00

54,669.00

49,457

Capital Expenditures

132.00

193.00

412.00

551.00

737.00

Sale of Fixed Assets & Businesses

1.00

Net Investing Cash Flow

131.00

193.00

412.00

551.00

737.00

Net Financing Cash Flow

54,538.00

11,442.00

98,336.00

788.00

45,299.00

Net Change in Cash

5,102.00

25,401.00

97,914.00

59,664.00

10,107.00

Free Cash Flow

59,641.00

36,843.00

422.00

58,876.00

55,406.00

Change in Capital Stock